# Pharmaceutical and Healthcare Lobbying

Purpose: short reference and outline for the "Pharmaceutical and Healthcare Lobbying" module.

Status: sourced

Tags: mechanics, incentives, power-concentration

Outline: see `outline.md`

Contributors: add names and links here

Related modules: 079, 083, 085, 072
Last reviewed: 2026-02

Actors:
	- name: PhRMA, BIO, and pharmaceutical trade associations
		type: institution
	- name: Former FDA officials in industry roles
		type: political_entity
	- name: Senate Finance and House Energy and Commerce Committee members
		type: office

Statutes:
	- Federal Food, Drug, and Cosmetic Act (21 U.S.C. ยง 301 et seq.)
	- Prescription Drug User Fee Act (PDUFA, P.L. 102-571)

Cases:
	- FTC v. Actavis, 570 U.S. 136 (2013)
	- Sorrell v. IMS Health, 564 U.S. 552 (2011)

How to contribute:

- Add citations to `outline.md` under "Suggested sources"
- Propose visuals in `figures/` and link from this README
